Lu177 PSMA Therapy
Your health, our priority – We offer you the finest treatment with personalized care that goes beyond treatment. Reach out to us today.
Overview
Prostate cancer remains one of the most common cancers in men worldwide, and in advanced stages, it can spread beyond the prostate gland, making treatment challenging. For patients whose cancer has become resistant to traditional therapies, Lutetium-177 Prostate-Specific Membrane Antigen (Lu177 PSMA) therapy offers a promising solution.
India has emerged as a leading destination for Lu177 PSMA therapy due to its cutting-edge nuclear medicine facilities, experienced oncologists, and affordable treatment costs compared to Western countries. This targeted therapy is particularly beneficial for metastatic castration-resistant prostate cancer (mCRPC) patients who have exhausted other treatment options.
This guide covers the procedure, benefits, eligibility, cost details, top hospitals, and FAQs—giving patients and caregivers all the information they need to make informed decisions.
What is Lu177 PSMA Therapy?
Lu177 PSMA therapy is a form of targeted radionuclide therapy used to treat advanced prostate cancer. It works by delivering radiation directly to cancer cells while sparing most healthy tissue.
How It Works
- PSMA is a protein highly expressed on prostate cancer cells.
- The therapy uses a molecule that binds to PSMA and is labeled with Lutetium-177, a radioactive isotope.
- Once injected into the body, the molecule seeks out PSMA-expressing cancer cells.
- The Lutetium-177 delivers precise radiation to kill the cancer cells from within.
Who is Eligible for Lu177 PSMA Therapy?
Patients may be considered for Lu177 PSMA therapy if they:
- Have metastatic castration-resistant prostate cancer (mCRPC).
- Have previously undergone hormone therapy, chemotherapy, or other systemic treatments without desired results.
- Have a positive PSMA PET/CT scan confirming the presence of PSMA receptors on tumor cells.
- Are in adequate general health to tolerate the therapy.
Procedure of Lu177 PSMA Therapy in India
- Initial Assessment
- Medical evaluation and review of cancer history.
- PSMA PET/CT scan to confirm eligibility.
- Preparation
- Blood tests, kidney, and liver function assessments.
- Patient counseling regarding the process and possible side effects.
- Therapy Administration
- Lu177 PSMA is injected intravenously.
- The procedure is painless and takes about 30–60 minutes.
- Patients may be observed for a few hours post-injection.
- Post-Treatment Care
- Increased fluid intake to help flush out excess radioactivity.
- Follow-up visits for monitoring progress.
- Repeat sessions are usually done every 6–8 weeks, with a total of 4–6 cycles recommended.
Benefits of Lu177 PSMA Therapy
- Targeted Action – Minimizes damage to healthy cells.
- Effective for Advanced Stages – Offers hope for patients with limited options.
- Improved Quality of Life – Reduces pain and tumor burden.
- Minimal Side Effects – Lower toxicity compared to chemotherapy.
Potential for Disease Control – Can slow disease progression and extend survival.
Top Hospitals for Lu177 PSMA Therapy in India
India hosts several internationally recognized hospitals offering this therapy:
- Tata Memorial Hospital, Mumbai
- Apollo Hospitals, Chennai & Delhi
- Fortis Memorial Research Institute, Gurgaon
- Medanta – The Medicity, Gurgaon
- Narayana Health, Bangalore
- Kokilaben Dhirubhai Ambani Hospital, Mumbai
These hospitals have nuclear medicine departments equipped with state-of-the-art technology and experienced oncology teams.
Why Choose India for Lu177 PSMA Therapy?
- Cost-Effective – Up to 70% cheaper than in the USA or Europe.
- Expert Specialists – Oncologists trained at top global institutions.
- Advanced Facilities – PET/CT imaging, precision dosing, and safety protocols.
- Short Waiting Times – Quicker access to treatment.
- Comprehensive Care – End-to-end patient support for international medical tourists.
Possible Side Effects of Lu177 PSMA Therapy
While generally well-tolerated, some patients may experience:
- Fatigue
- Dry mouth (xerostomia)
- Mild nausea
- Low blood counts (anemia, thrombocytopenia)
- Kidney function changes (rare)
Doctors closely monitor patients to manage side effects and maintain safety.
Post-Treatment Guidelines
- Maintain hydration for 2–3 days post-therapy.
- Avoid prolonged close contact with young children and pregnant women for a few days.
- Follow all radiation safety instructions.
- Attend scheduled follow-up appointments for monitoring.
Conclusion
Lu177 PSMA therapy in India offers new hope for men with advanced prostate cancer, providing targeted radiation directly to cancer cells while minimizing side effects. With highly skilled specialists, world-class facilities, and costs significantly lower than in the West, India is an excellent choice for patients seeking effective treatment without financial strain.
Early consultation with a nuclear medicine specialist is key to determining eligibility and planning the best treatment approach. By choosing India, patients gain access to personalized care, advanced technology, and compassionate support—all contributing to improved quality of life and better outcomes.
Top Hospitals for Lu177 PSMA Therapy
Below are the list of the top hospitals that are known for Lu177 PSMA Therapy procedures:
Max Super Speciality Hospital, Dwarka
Established in: 2024
Number of Beds: 300
Multi Specialty
Location: New Delhi
MIOT International Hospital, Chennai
Established in: 1999
Number of Beds: 1000
Multi Specialty
Location: Chennai, India
Asian Institute of Medical Sciences, Faridabad
Established in: 2010
Number of Beds: 425
Super Specialty
Location: Faridabad, India
PSRI hospital, Saket
Established in: 1996
Number of Beds: 106
Multi Specialty
Location: saket, New Delhi
Kokilaben Dhirubhai Ambani Hospital Mumbai
Established in: 2008
Number of Beds: 750
Multi Specialty
Location: Mumbai
CK Birla Hospital, Gurugram
Established in: 2017
Number of Beds: 90
Multi Specialty
Location: Gurugram
Saifee Hospital Mumbai
Established in: 1948
Number of Beds: 257
Multi Specialty
Location: Mumbai
Apollo Hospital Mumbai
Established in: 1983
Number of Beds: 500
Multi Specialty
Location: Mumbai
Jaslok Hospital Mumbai
Established in: 1973
Number of Beds: 350
Multi Specialty
Location: Mumbai
Medicover Hospital HiTec City Hyderabad
Established in: 2011
Number of Beds: 250
Super Specialty
Location: Hyderabad
Our Services
Transparent • Professional • Without Hassles
Compare Cost Estimates
Get detailed cost breakdowns and compare prices across multiple hospitals
Book Doctor Appointment
Schedule appointments with top specialists at your convenience
Hospitalisation Support
Complete assistance from admission to discharge with dedicated care
Video Consultation
Consult doctors online or in-person based on your preference
Travel Assistance
Visa support, flight booking, and airport pickup services
Language Interpreter
Multilingual support to ensure clear communication
Accommodation
Comfortable stay arrangements near the hospital
24/7 Support
Round-the-clock assistance for all your medical needs
Top Lu177 PSMA Therapy Specialists
Dr. Meenu Walia
4.0
Experience: 27 years of experience
Education: Director , MBBS, MS, DNB
Get a free consultancy
Dr. Rakesh Chopra
4.0
Experience: 15 years of experience
Education: HOD , MBBS, MD
Get a free consultancy
Dr. Akshay Tiwari
New Delhi4.0
Experience: 18 Years of Experience
Education: Head of Department , Fellowship, Diploma, MS, MBB
Get a free consultancy
Dr. Malay Nandy
Noida4.0
Experience: 38
Education: MBBS, MD, DM
Get a free consultancy
Dr. Kapil Kumar
Delhi4.0
Experience: 45
Education: BBS, MS, FICS
Get a free consultancy
Dr. Dharma Choudhary
Gurugram4.0
Experience: 28
Education: MBBS, MD , DM, Fellowship
Get a free consultancy
Dr. Biswajyoti Hazarika
Gurgaon4.0
Experience: 20
Education: MBBS , MS , Fellowship
Get a free consultancy
Dr. Praveen Bansal
Faridabad, India4.0
Experience: 25
Education: MBBS , MD , DM
Get a free consultancy
Dr. Kanchan Kaur
4.0
Experience: 17 years of experience
Education: Senior Consultant , MBBS, MS, MS
Get a free consultancy
Dr. Rajasundaram
Chennai, India4.0
Experience: 32
Education: MBBS, MS, MCh, DNB, FAIS, FAMS
Get a free consultancy
Get Free Consultation
Fill out the form below and our team will get back to you shortly
Treatment Costs in India
Cost of Lu177 PSMA Therapy in India
India offers Lu177 PSMA therapy at significantly lower costs than in many developed countries, without compromising quality. The cost depends on:
- The number of therapy cycles needed.
- The hospital and city.
- Whether the patient requires additional supportive treatments.
Cost Breakdown Table – Lu177 PSMA Therapy in India
| Treatment Component | Cost per Cycle (INR) | Cost per Cycle (USD) |
| Consultation & Diagnostic Tests | ₹10,000 – ₹20,000 | $120 – $240 |
| Lu177 PSMA Dose & Administration | ₹4,50,000 – ₹6,00,000 | $5,400 – $7,200 |
| Hospital Stay (if required) | ₹5,000 – ₹10,000 | $60 – $120 |
| Supportive Medications | ₹5,000 – ₹15,000 | $60 – $180 |
| Estimated Total per Cycle | ₹4,70,000 – ₹6,45,000 | $5,640 – $7,740 |
Most patients require 4–6 cycles, so the total treatment cost may range from ₹18,80,000 – ₹38,70,000 ($22,560 – $46,440).
Frequently Asked Questions
FAQs
- How many cycles of Lu177 PSMA therapy are usually required?
Most patients require 4–6 cycles, spaced 6–8 weeks apart, depending on the response. - Is Lu177 PSMA therapy a cure for prostate cancer?
It is not a cure for advanced prostate cancer but can significantly control the disease, reduce symptoms, and improve quality of life. - How soon will I see results?
Many patients report symptom improvement within a few weeks after the first cycle, but full benefits are seen after multiple cycles. - Can international patients get this treatment in India?
Yes. Many hospitals have dedicated international patient departments to assist with travel, visas, accommodation, and treatment scheduling. - Does insurance cover Lu177 PSMA therapy in India?
Coverage depends on the insurance provider. International patients should check with their insurer, while Indian patients can explore corporate or private health insurance options. - Is hospitalization necessary after each session?
In most cases, it is given as an outpatient procedure, but some patients may require a short hospital stay for observation. - What is the survival rate after Lu177 PSMA therapy?
Survival varies depending on disease stage and patient health, but studies have shown improved progression-free and overall survival rates. - Can Lu177 PSMA therapy be combined with other treatments?
Yes, it can be combined with hormone therapy or chemotherapy based on the oncologist’s recommendation. - Are there age restrictions for this treatment?
No fixed age limit exists, but overall health and organ function are important factors. - Is the therapy painful?
No, the injection process is painless, similar to a regular IV infusion. - How do I prepare for the treatment?
Patients should undergo prescribed diagnostic tests, stay well-hydrated, and follow any fasting or medication instructions given by the doctor.